Gpcr subfamily sequence motifs, and methods for gpcr characterization
CA 2400521 A1 · Owner: Pfizer Products Inc. · Inventors: Huang, Enoch So-Wei
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the field of bioinformatics. More particularly the, invention relates to methods of identifying sequence motifs characteristic of G-, protein-coupled receptor (GPCR) subfamilies and using these motifs for , example, to, classify "orphan GPCRs." The invention provides methods of classifying "orphan GPCRs" that focus on amino acid residue similarities for ligand-binding positions. The, methods use optimized sequence alignments and avoid mechanical calculation of scores and cutoffs. In particular, a sequence motif characteristic of a GPCR subfamily that binds a certain ligand type is determined and "orphan GPCRs" , having, the sequence motif are assigned to the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 29, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 29, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 29, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.